CSL:ASX
CSL Ltd
A$174.50
arrow_downward
-0.57%(-1.00) 1D
Sep 4, 4:17:26 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$176.55
High
A$177.39
Low
A$173.93
Mkt. cap
83.57B
Avg. vol.
1.47M
Volume
1.07M
Dividend
1.65%
Quarterly dividend
A$0.72
Ex-dividend date
Sep 9, 2026
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.49
Shares outstanding
478.91M
No. of employees
29K
Open
A$176.55
High
A$177.39
Low
A$173.93
Mkt. cap
83.57B
Avg. vol.
1.47M
Volume
1.07M
Dividend
1.65%
Quarterly dividend
A$0.72
Ex-dividend date
Sep 9, 2026
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.49
Shares outstanding
478.91M
No. of employees
29K
News stories
From web sources and news partners
Kalkine Media
·
12 hours ago
Could CSL (ASX:CSL) Draw Attention in Technical Analysis as Healthcare Stocks Rebound?
Kalkine Media
·
16 hours ago
(ASX:CSL) and (ASX:NXT) Lead ASX Shares Re-Rated After Results
Kalkine
·
22 hours ago
CSL Limited Issues 834,408 Ordinary Shares Following Performance Rights Exercise
TipRanks
·
22 hours ago
CSL Notifies Cessation of CSLAL Rights Securities on ASX
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com